Khushbu Patel

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Epigenomic profiling of neuroblastoma cell lines”.

Epigenomic profiling of neuroblastoma cell lines

Scientific Data(2020)10.1038/s41597-020-0458-y

N/A

0DataRank · unranked

76 citations

Apexa Modi, Khushbu Patel, Nathan M. Kendsersky, Karina L. Conkrite, Robyn T. Sussman +8 more

A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100344

N/A

0DataRank · unranked

34 citations

Samantha N. Buongervino, Maria Lane, Doncho V. Zhelev, Zhongyu Zhu, Hong Cui +15 more

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma

Communications Biology(2022)10.1038/s42003-022-04209-8

N/A

0DataRank · unranked

24 citations

Minu Samanta, Paul Martorano, Hwan Lee, Sarah B. Gitto, Khushbu Patel +18 more

ROGUE: an R Shiny app for RNA sequencing analysis and biomarker discovery

BMC Bioinformatics(2023)10.1186/s12859-023-05420-y

N/A

0DataRank · unranked

6 citations

Peng Li, Sharon Veenbergen, Khushbu Patel, John M. Maris, Warren J. Leonard +1 more

A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN -amplified neuroblastoma

Science Advances(2023)10.1126/sciadv.adg6693

N/A

0DataRank · unranked

6 citations

Alberto Delaidelli, Sumreen Javed, Busra Turgu, Taylor Morrison, Christopher S. Hughes +17 more

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.06.570390

N/A

0DataRank · unranked

5 citations

Alexander B. Radaoui, Matthew Tsang, Daniel Martínez, Simone Sidoli, Karina L. Conkrite +31 more

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

Cancer Cell(2024)10.1016/j.ccell.2024.10.003

N/A

0DataRank · unranked

18 citations

Alexander B. Radaoui, Matthew Tsang, Daniel Martínez, Karina L. Conkrite, Khushbu Patel +33 more

Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-24-0684

N/A

0DataRank · unranked

4 citations

Michael P. East, Timothy J. Stuhlmiller, Gabriela M. Witek, Alvin Farrel, Steven Pastor +13 more

A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers

Nature Communications(2025)10.1038/s41467-025-62979-1

N/A

0DataRank · unranked

4 citations

Smita Matkar, Christina Acholla, Colleen E. Casey, Grant Li, Martina Mazzeschi +28 more

Kinome reprogramming of G2/M kinases and repression of MYCN contribute to superior efficacy of lorlatinib in ALK-driven neuroblastoma.

UNC Libraries(2025)10.17615/pbz0-mn14

N/A

0DataRank · unranked

0 citations

Mark Gerelus, Michael P. East, Alvin Farrel, Steven Pastor, John M. Maris +13 more